136 results
Page 3 of 7
424B5
501cixyfw 93zkhfy
28 May 20
Prospectus supplement for primary offering
12:00pm
6-K
EX-99
vokeo0g6 ed
28 May 20
Current report (foreign)
11:56am
6-K
EX-99
f38 hqzmjc
28 Jun 19
BioLineRx Announces Change in Ratio of American
4:01pm
20-F/A
4ni0v
5 Jun 19
Annual report (foreign) (amended)
7:00am
6-K
EX-99
sftby47aku0t93h0dvbb
7 Feb 19
As Representative of the several Underwriters
12:00pm
424B5
fbartmta
5 Feb 19
Prospectus supplement for primary offering
5:12pm
424B5
jfgaecodyhgbc8tc54
4 Feb 19
Prospectus supplement for primary offering
5:52pm
6-K
44nqotjal
4 Feb 19
Current report (foreign)
4:30pm
6-K
EX-99.2
w3r1tgjf42g k3w3rxoc
4 Feb 19
Current report (foreign)
4:30pm
6-K
EX-10.3
jyjd0fk5lkg0w3s79
3 Oct 18
BioLineRx Increases Stake in BL-8040, its Lead Oncology
6:03am